Association of Helicobacter pylori infection with chemotherapy-induced thrombocytopenia in patients with stage III colon cancer: A pilot study

References

• Corrado E, Nova S. Role of inflammation and infection in vascular disease. Acta Chir Belg 2005; 105: 567–579
   PubMed Web of Science ®Google Scholar
• Oshima T, Ozano R, Yano Y, Oishi Y, Teregawa H, Higashi Y, Yoshizumi M, Kambe M. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Collage Cardiol 2005; 45: 1219–1222
   PubMedGoogle Scholar
• Woodward M, Morrison C, Mccoll K. An investigation into factors associated with Helicobacter pylori infection. J Clin Epidemiol 2000; 53: 175–181
   PubMedGoogle Scholar
• Rosenstock SJ, Jorgensen T, Andersen LP, Bonnevic O. Association of Helicobacter pylori infection with lifestyle, chronic diseases, body-indices and age at menarche in Danish adults. Scand J Public Health 2000; 28: 32–40
   PubMed Web of Science ®Google Scholar
• Tanriverdi O. Association of Helicobacter pylori infection with microalbuminuria in type 2 diabetic patients. Turk J Gastroenterol 2011; 22: 569–574
   PubMedGoogle Scholar
• Innocenti M, Thoresan AC, Ferrera RL, Strömberg E, Bölin I, Eriksson L, Svennerholm AM, Quiding-Jarbrink M. Helicobacter pylori-induced activation of human endothelial cells. Infection and Immunity 2002; 70: 4581–4590
   PubMed Web of Science ®Google Scholar
• Limburg PJ, Stolzenberg-Solomon RZ, Colbert LH, Perez-Perez GI, Blaser MJ, Taylor PR, Virtamo J, Albanes D. Helicobacter pylori seropositivity and colorectal cancer risk: A prospective study of male smokers. Cancer Epidemiol Biomarkers Prev 2002; 11(10 Pt 1)1095–1099
   PubMed Web of Science ®Google Scholar
• Hunt R, Thomson ABR. Canadian Helicobacter pylori consensus conferenca. Can J Gastroenterol 1998; 12: 31–41
   PubMed Web of Science ®Google Scholar
• Colocci G, Gebbia V, Paoletti G, Giuliani F, Caruso M, Gebbia N, Cartenì G, Agostara B, Pezzella G, Manzione L, , Gruppo Oncologico Dell'Italia Meridionale, et al. Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer:a multicenter study of the Gruppo Oncologica Dell’Italia Meridionale. J Clin Oncol 2005; 23: 4866–4875
   PubMedGoogle Scholar
• Andre T, Boni C, Mounedji-Boudiaf L. Oxaliplatin, fluorouracil, and leucovorin an adjuvant treatment for colon cancer. N Engl J Med 2004; 350: 2343–2352
   PubMed Web of Science ®Google Scholar
• Ahn YS. Triple play of H. pylori in ITP. Blood 2010; 115: 4155–4156
   PubMed Web of Science ®Google Scholar
• Shaikh KH, Ahmed S, Ayyub M, Anwar J. Association of Helicobacter pylori infection with idiopathic thrombocytopenic purpura. J Pak Med Assoc 2009; 59: 660–663
   PubMedGoogle Scholar
• Stasi R, Provan D. Helicobacter pylori and chronic ITP. Am Soc Hematol Educ Prog 2008; 206–211, doi: 10.1182/asheducation-2008.1.206
   PubMedGoogle Scholar
• McCrae KR. Helicobacter pylori and ITP: Many questions, few answers. Blood 2004; 103: 752–753
   Web of Science ®Google Scholar
• Franchini M, Cruciani M, Mengoli C, Pizzolo G, Veneri D. Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: A systematic review and meta-analysis. J Antimicrob Chemother 2007; 60: 237–246
   PubMed Web of Science ®Google Scholar
• Stasi R, Sarpatwari A, Segal JB, Osborn J, Evangelista ML, Cooper N, Provan D, Newland A, Amadori S, Bussel JB. Effects of eradication of Helicobacter pylori infection in patients in patients with immune thrombocytopenic purpura: A systematic review. Blood 2009; 113: 1231–1240
   PubMed Web of Science ®Google Scholar
• Bennett D, Voest EE, Huisman A, van Solinge WW, Egberts TC. Thrombocytopenia in adult cancer patients receiving cytotoxic chemotherapy: Results from a retrospective hospital-based cohort study. Drug Saf 2011; 34: 1151–1160
   PubMedGoogle Scholar
• Jelic S, Radulovic S. Chemotherapy-associated thrombocytopenia: Current and emerging management strategies. Am J Cancer 2006; 6: 372–382
   Google Scholar
• Sekhon SS, Roy V. Thrombocytopenia in adults: A practical approach to evaluation and management. South Med J 2006; 99: 491–498
   PubMedGoogle Scholar
• Arnold DM, Lim W. A rational approach to the diagnosis and management of thrombocytopenia in the hospitalized patient. Semin Hematol 2011; 48: 251–258
   PubMed Web of Science ®Google Scholar
• Strofilas A, Lagoudianakis EE, Seretis C, Pappas A, Koronakis N, Keramidaris D, Koukoutsis I, Chrysikos I, Manouras I, Manouras A. Association of Helicobacter pylori infection and colon cancer. J Clin Med Res 2912; 4: 172–176
   Google Scholar
• Salehi Z, Miri M, Aminian K, Mansour-Ghanaei F. Helicobacter pylori infection and colorectal cancer in Guilan province of Iran. Ann Biol Res 2011; 2: 32–39
   Google Scholar
• Burnett-Hartman AN, Newcomb PA, Potter JD. Infectious agents and colorectal cancer: A review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus. Cancer Epidemiol Biomarkers Prev 2008; 17: 2970–2979
   PubMed Web of Science ®Google Scholar
• Jones M, Helliwell P, Pritchard C, et al. Helicobacter pylori in colorectal neoplasms: Is there an aetiological relationship?. World J Surg Oncol 2007; 5: 51–56
   PubMedGoogle Scholar
• Soylu A, Ozkara S, Alıs H, Dolay K, Kalayci M, Yasar N, Kumbasar AB. Immunohistochemical testing for Helicobacter pylori existence in neoplasms of the colon. BMC Gastroenterol 2008; 8: 35–40
   PubMedGoogle Scholar
• Zhang Y, Hoffmeister M, Weck MN, Chang-Claude J, Brenner H. Helicobacter pylori infection and colorectal cancer risk: Evidence from a large population-based case-control study in Germany. Am J Epidemiol 2012; 175: 441–450
   PubMed Web of Science ®Google Scholar